These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33059578)

  • 1. Gestational Exposure to Serotonin Reuptake Inhibitors and Pregnancy Outcome; Exploring the Role of Bias and Confounders.
    Koren G; Ornoy A
    Curr Neuropharmacol; 2021; 19(12):2227-2232. PubMed ID: 33059578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
    Rahimi R; Nikfar S; Abdollahi M
    Reprod Toxicol; 2006 Nov; 22(4):571-5. PubMed ID: 16720091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?
    Ornoy A; Koren G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
    Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
    Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
    Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.
    Hallberg P; Sjöblom V
    J Clin Psychopharmacol; 2005 Feb; 25(1):59-73. PubMed ID: 15643101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors for depression in pregnancy.
    Susser LC; Sansone SA; Hermann AD
    Am J Obstet Gynecol; 2016 Dec; 215(6):722-730. PubMed ID: 27430585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE; Oberlander TF
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
    Malm H; Klaukka T; Neuvonen PJ
    Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis.
    Kautzky A; Slamanig R; Unger A; Höflich A
    Acta Psychiatr Scand; 2022 Jan; 145(1):6-28. PubMed ID: 34486740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.